International Online Chongqing Channel News: on April 13, Chongqing Liangjiang New District held the signing activity of the project of the Research Institute of biological intelligent manufacturing. Duan Chenggang, member of the Standing Committee of Chongqing municipal Party committee, Secretary of the Party Working Committee and director of the Management Committee of Liangjiang New Area, attended the activity.

It is understood that the project of bio Intelligent Manufacturing Research Institute will rely on the talent advantages of the national key field innovation research team and the technical advantages of the national key R & D plan project, and carry out the design and development, clinical trials, research and development of the bio intelligent manufacturing technology with 3D printing manufacturing technology characteristics and the key, core, common (clinical and certification) technology and product system of three types of implantable medical devices Product certification, achievement transformation, etc.

Wang Zhijie, deputy secretary of the Party Working Committee and executive deputy director of the Management Committee of Liangjiang New Area, said in his speech that after years of development, the big health industry of Liangjiang New Area has attracted a number of well-known innovation institutions and enterprise groups in the field of big health at home and abroad. At present, Liangjiang New Area is seizing the market opportunity generated by the epidemic, building a 100 billion level health industry cluster, and building Chongqing International Life Science valley. The project of bio Intelligent Manufacturing Research Institute is committed to using the concept of intelligent manufacturing to protect life and health. It will gather more high-end R & D talents and create an industrial innovation demonstration of deep integration of "government, industry, University, research and application (Medicine)" in the field of bio intelligent manufacturing, which will help to promote the development of big health industry and the construction of smart city in the new district. Liangjiang New Area will focus on providing high-quality, efficient, convenient and comprehensive services for enterprises and research institutes.

As one of the initiators, Chongqing Xike Medical Technology Co., Ltd. is a key enterprise focusing on the industrialization of three kinds of implantable medical devices in Liangjiang New Area. It will implement more than 10 innovative three kinds of medical devices in five years, forming a rich implantable product system. The company, led by Chongqing Zhirui investment, will become another major layout of Zhirui investment in addition to vaccines and gene therapy. Jiang Rensheng, chairman of Zhirui investment, said that Liangjiang New Area has good location advantages, industrial advantages and first-class business environment. Zhirui investment will focus on bio intelligent manufacturing and gradually increase investment in Liangjiang New Area. The project team will also make concerted efforts to make the project bigger, stronger and better, and contribute to the high-quality development of Liangjiang New Area.

At present, the status of the three types of implantable medical devices in the field of the project in the whole industry is gradually improving, and import substitution has become a major trend. In 2018, its global operating revenue exceeded 50 billion US dollars. Since 2013, the core technology team of the project of the Institute of bio intelligent manufacturing has been involved in the application of metal 3D printing technology, equipment development, three kinds of implant product development and clinical trials. In 2016, it was approved as the first national key R & D plan for 3D printing in China. At present, it has reserved a batch of original process data, passed a series of preclinical tests, and carried out clinical trials, which has achieved significant demonstration effect.

Since the beginning of this year, Liangjiang New Area has actively carried out investment promotion and continuously enabled the development of big health industry. A number of high-quality projects, such as Saiye bio innovative drug R & D service platform, bangze biotransformation project and Liangjiang headquarters base of pharmaceutical industry, have been settled in succession.

It is worth mentioning that on March 14, Liangjiang New Area held a special "cloud signing" activity for key investment promotion projects of big health biomedicine, with a total investment of 8.318 billion yuan.

In the next step, Liangjiang New Area will continue to increase the investment attraction of health industry, attract more high-quality enterprises, gather more talents in the field of big health, integrate relevant resources, and continuously improve the energy level and level of big health industry.

The signing activity was presided over by Li Shun, member of the Party Working Committee and deputy director of the Management Committee of Liangjiang New Area. PI Tao, member of the Party Working Committee and deputy director of the Management Committee of Liangjiang New Area, person in charge of relevant units of Liangjiang New Area, person in charge of Zhirui investment and Xike medical attended the activity（ Wenwang Jingming (editor Hu Mingzhu)

Source: International Online Chongqing channel